Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Entecavir 1 mg Tablets vs Baraclude 1 mg Tablets in Healthy Thai Volunteers Under Fasting Conditions
TCTR20230320001Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of entecavir in hepatitis B (HBV) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on TCTR20230320001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230320001.